Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Voyager Therapeutics (VYGR) Construction in Progress (2016)

Historic Construction in Progress for Voyager Therapeutics (VYGR) over the last 1 years, with Q4 2016 value amounting to $3.0 million.

  • Voyager Therapeutics' Construction in Progress changed N/A to $3.0 million in Q4 2016 from the same period last year, while for Dec 2016 it was $3.0 million, marking a year-over-year change of. This contributed to the annual value of $3.0 million for FY2016, which is N/A changed from last year.
  • As of Q4 2016, Voyager Therapeutics' Construction in Progress stood at $3.0 million.
  • Over the past 5 years, Voyager Therapeutics' Construction in Progress peaked at $3.0 million during Q4 2016, and registered a low of $3.0 million during Q4 2016.